Potential Benefits of Expanded COVID-19 Surveillance in the US
JAMA
.
2021 Aug 3;326(5):381-382.
doi: 10.1001/jama.2021.11211.
Authors
David R Holtgrave
1
,
Sten H Vermund
2
,
Leana S Wen
3
Affiliations
1
University at Albany School of Public Health, State University of New York, New York.
2
Yale School of Public Health, New Haven, Connecticut.
3
Fitzhugh Mullan Institute for Health Workforce Equity, George Washington University, Washington, DC.
PMID:
34264262
PMCID:
PMC10767713
DOI:
10.1001/jama.2021.11211
No abstract available
MeSH terms
Asymptomatic Infections / epidemiology
COVID-19 / epidemiology*
COVID-19 / mortality
Centers for Disease Control and Prevention, U.S.
Humans
Public Health Surveillance*
United States / epidemiology
Vaccination
Grants and funding
P30 MH062294/MH/NIMH NIH HHS/United States
R03 DA052179/DA/NIDA NIH HHS/United States